206 related articles for article (PubMed ID: 15117087)
1. Vardenafil--PDE5 inhibitor number 3.
Jackson G
Int J Clin Pract; 2004 Mar; 58(3):229. PubMed ID: 15117087
[No Abstract] [Full Text] [Related]
2. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
Mason RG
J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189
[No Abstract] [Full Text] [Related]
3. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
Katsarov M
Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
[No Abstract] [Full Text] [Related]
4. Vardenafil: a review of its use in erectile dysfunction.
Keating GM; Scott LJ
Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies.
McCullough A
Curr Urol Rep; 2004 Dec; 5(6):451-9. PubMed ID: 15541215
[TBL] [Abstract][Full Text] [Related]
6. [New PDE-5 inhibitor for treatment of impotence. 9 out of 10 have erections again].
MMW Fortschr Med; 2003 Jun; 145(26):59. PubMed ID: 12916343
[No Abstract] [Full Text] [Related]
7. Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction.
Kendirci M; Bivalacqua TJ; Hellstrom WJ
Expert Opin Pharmacother; 2004 Apr; 5(4):923-32. PubMed ID: 15102574
[TBL] [Abstract][Full Text] [Related]
8. Vardenafil.
Young JM
Expert Opin Investig Drugs; 2002 Oct; 11(10):1487-96. PubMed ID: 12387708
[TBL] [Abstract][Full Text] [Related]
9. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
Thadani U; Smith W; Nash S; Bittar N; Glasser S; Narayan P; Stein RA; Larkin S; Mazzu A; Tota R; Pomerantz K; Sundaresan P
J Am Coll Cardiol; 2002 Dec; 40(11):2006-12. PubMed ID: 12475462
[TBL] [Abstract][Full Text] [Related]
10. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study.
Klotz T; Sachse R; Heidrich A; Jockenhövel F; Rohde G; Wensing G; Horstmann R; Engelmann R
World J Urol; 2001 Feb; 19(1):32-9. PubMed ID: 11289568
[TBL] [Abstract][Full Text] [Related]
11. Oral drug treatment of erectile dysfunction.
Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
[No Abstract] [Full Text] [Related]
12. Vardenafil: a new approach to the treatment of erectile dysfunction.
Hellstrom WJ
Curr Urol Rep; 2003 Dec; 4(6):479-87. PubMed ID: 14622502
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C
J Androl; 2004; 25(4):625-9. PubMed ID: 15223851
[TBL] [Abstract][Full Text] [Related]
14. Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.
Markou S; Perimenis P; Gyftopoulos K; Athanasopoulos A; Barbalias G
Int J Impot Res; 2004 Dec; 16(6):470-8. PubMed ID: 15229625
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'.
Perimenis P
Expert Opin Pharmacother; 2005 Jan; 6(1):1-2. PubMed ID: 15709877
[No Abstract] [Full Text] [Related]
16. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
Donatucci C; Eardley I; Buvat J; Gittelman M; Kell P; Segerson T; Homering M; Montorsi F;
J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960
[TBL] [Abstract][Full Text] [Related]
17. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
Vickers MA; Satyanarayana R
Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
[TBL] [Abstract][Full Text] [Related]
19. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 5 inhibitors in male sexual dysfunction.
Kuthe A
Curr Opin Urol; 2003 Sep; 13(5):405-10. PubMed ID: 12917517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
